Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

1779

Actual shortage: 173 (10%)
Anticipated shortage: 4 (0%)
Avoided shortage: 7 (0%)
Resolved: 1595 (90%)

Discontinuation Reports

343

To be discontinued: 21 (6%)
Discontinued: 322 (94%)
Reversed: 0 (0%)

Late reports

120 (6%)

Overdue reports

22 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2018-01-22 2018-06-12 36817
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2018-01-31 2018-05-05 37732
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-01 2018-05-24 37963
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-01 2018-06-04 37966
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-06 2018-07-03 38815
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-13 2018-07-03 39659
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-21 2018-03-08 40336
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2018-03-27 2018-07-03 44102
APO-ISMN 60MG TABLET (EXTENDED-RELEASE) Resolved 2018-05-22 2018-08-09 50044
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-04 2018-08-01 54285
APO-DICLO SR 100MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-11 2020-01-07 55264
APO-DICLO SR 75MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-11 2020-01-07 55267
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-11 2018-08-01 55299
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-16 2018-10-02 55836
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-25 2018-10-25 56541
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2018-10-25 2018-11-22 65599
APO-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-09 2020-11-03 66543
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-30 2019-06-13 68225
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-18 2019-01-28 69915
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-18 2019-07-17 69918

Showing 1681 to 1700 of 1779

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-HYDROCHLOROTHIAZIDE Discontinued 2019-11-26 2019-11-26 99653
APO-IMIQUIMOD Discontinued 2019-11-26 2019-11-26 99672
APO CARBAMAZEPINE TAB 200MG Discontinued 2020-02-19 2020-02-19 106679
APO-NIZATIDINE 150MG CAPSULE Discontinued 2017-03-13 2017-03-13 1127
APO-NIZATIDINE 300MG CAPSULE Discontinued 2017-03-13 2017-03-13 1135
APO-NORTRIPTYLINE - CAP 10MG 10MG CAPSULE Discontinued 2017-03-13 2017-03-13 1145
APO-NORTRIPTYLINE - CAP 25MG 25MG CAPSULE Discontinued 2017-03-13 2017-03-13 1155
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-DOCUSATE SODIUM 100MG CAPSULE Discontinued 2018-02-23 2019-03-29 40733
DOCUSATE SODIUM CAPSULES 100MG CAPSULE Discontinued 2018-02-23 2018-09-15 40738
APO-AMOXI 250MG CAPSULE Discontinued 2018-09-07 2019-02-13 60171
APO-AMOXI 500MG CAPSULE Discontinued 2018-09-07 2018-11-09 60174
APO-ATOMOXETINE 60MG CAPSULE Discontinued 2018-09-07 2018-09-15 60273
APO-CELECOXIB 100MG CAPSULE To be discontinued 2018-09-07 2018-12-11 60363
APO-CELECOXIB 200MG CAPSULE Discontinued 2018-09-07 2021-01-21 60366
APO-CLINDAMYCIN 150MG CAPSULE To be discontinued 2018-09-07 2018-12-28 60396
APO-CLINDAMYCIN 300MG CAPSULE Discontinued 2018-09-07 2019-07-13 60399

Showing 41 to 60 of 343